These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22335128)

  • 1. [Sleep disorders in the preclinical period of the Alzheimer's disease].
    Bidzan L; Grabowski J; Dutczak B; Bidzan M
    Psychiatr Pol; 2011; 45(6):851-60. PubMed ID: 22335128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia].
    Bidzan M; Bidzan L
    Psychiatr Pol; 2014; 48(2):319-30. PubMed ID: 25016769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric symptoms in patients with Alzheimer's disease with a vascular component.
    Bidzan M; Bidzan L; Pachalska M
    Ann Agric Environ Med; 2014; 21(2):412-5. PubMed ID: 24959800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and psychological symptoms in the preclinical stage of Alzheimer's disease.
    Bidzan L; Pachalska M; Grochmal-Bach B; Bidzan M; Cieslukowska A; Pufal A
    Med Sci Monit; 2008 Sep; 14(9):CR473-9. PubMed ID: 18758418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vascular factors and the psychopathological picture in Alzheimer's disease].
    Idzan LB; Bidzan M
    Psychiatr Pol; 2006; 40(5):823-31. PubMed ID: 17217228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
    Allan LM; Ballard CG; Burn DJ; Kenny RA
    J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frequency and intensity of behavioral and psychological symptoms in the course of Alzheimer's disease].
    Wasiak B; Gabryelewicz T; Łuczywek E; Pfeffer A; Czyzewski K; Styczyńska M; Gołebiowski M; Matysiak W; Barcikowska M
    Psychiatr Pol; 2001; 35(1):93-107. PubMed ID: 11324386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The psychopathological symptoms of the preclinical stages of Alzheimer's disease].
    Bidzan L
    Psychiatr Pol; 2001; 35(6):1019-32. PubMed ID: 11877882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
    Mizuno S; Kameda A; Inagaki T; Horiguchi J
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):660-5. PubMed ID: 15601392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep disturbance in mild to moderate Alzheimer's disease.
    Moran M; Lynch CA; Walsh C; Coen R; Coakley D; Lawlor BA
    Sleep Med; 2005 Jul; 6(4):347-52. PubMed ID: 15978517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric profiles of patients with Alzheimer's disease and vascular dementia in Taiwan.
    Hsieh CJ; Chang CC; Lin CC
    Int J Geriatr Psychiatry; 2009 Jun; 24(6):570-7. PubMed ID: 19051223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daytime sleepiness in mild Alzheimer's disease with and without parkinsonian features.
    Park M; Shah RC; Fogg LF; Wyatt JK
    Sleep Med; 2011 Apr; 12(4):397-402. PubMed ID: 21388877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep disturbances in Alzheimer's disease are associated with neuropsychiatric symptoms and antidementia treatment.
    García-Alberca JM; Lara JP; Cruz B; Garrido V; Gris E; Barbancho MÁ
    J Nerv Ment Dis; 2013 Mar; 201(3):251-7. PubMed ID: 23407210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
    Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
    Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting depression in Alzheimer's disease: evaluation of four different scales.
    Müller-Thomsen T; Arlt S; Mann U; Mass R; Ganzer S
    Arch Clin Neuropsychol; 2005 Mar; 20(2):271-6. PubMed ID: 15708735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
    Suh GH; Ju YS; Yeon BK; Shah A
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular factors and progression of cognitive decline in elderly people].
    Bidzan L; Bidzan M
    Psychiatr Pol; 2005; 39(5):987-95. PubMed ID: 16358597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.